ID

22459

Description

Study part: Investigational Product Discontinuation.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Mots-clés

  1. 05/06/2017 05/06/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

5 juin 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Investigational Product Discontinuation Mepolizumab HES NCT00086658

Investigational Product Discontinuation

INVESTIGATIONAL PRODUCT DISCONTINUATION
Description

INVESTIGATIONAL PRODUCT DISCONTINUATION

Alias
UMLS CUI-1
C0013230 (Investigational New Drugs)
UMLS CUI-2
C0457454 (Discontinuation (procedure))
Subject ID
Description

Subject ID

Type de données

text

Alias
UMLS CUI [1]
C2348585 (Clinical Trial Subject Unique Identifier)
Was the investigational product stopped permanently before the end of the scheduled treatment period?
Description

Investigational Product Discontinuation

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013230 (Investigational New Drugs)
UMLS CUI [1,2]
C0457454 (Discontinuation (procedure))
The primary reason the investigational product was stopped:
Description

Reason Investigational Product Discontinuation

Type de données

text

Alias
UMLS CUI [1,1]
C0392360 (Indication of (contextual qualifier))
SNOMED
230165009
LOINC
MTHU008319
UMLS CUI [1,2]
C0013230 (Investigational New Drugs)
UMLS CUI [1,3]
C0457454 (Discontinuation (procedure))
If other, please specify
Description

Other

Type de données

text

Alias
UMLS CUI [1]
C0205394 (Other)
SNOMED
74964007
LOINC
LP21049-9

Similar models

Investigational Product Discontinuation

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
INVESTIGATIONAL PRODUCT DISCONTINUATION
C0013230 (UMLS CUI-1)
C0457454 (UMLS CUI-2)
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Investigational Product Discontinuation
Item
Was the investigational product stopped permanently before the end of the scheduled treatment period?
boolean
C0013230 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
Item
The primary reason the investigational product was stopped:
text
C0392360 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
Code List
The primary reason the investigational product was stopped:
CL Item
Lost to follow-up (Lost to follow-up)
C1302313 (UMLS CUI-1)
CL Item
Protocol violation (Protocol violation)
C1709750 (UMLS CUI-1)
CL Item
Subject decided to withdraw from the study (Subject decided to withdraw from the study)
C2348571 (UMLS CUI-1)
CL Item
Lack of efficacy (Lack of efficacy)
C0235828 (UMLS CUI-1)
CL Item
Sponsor terminated study (Sponsor terminated study)
C1710224 (UMLS CUI-1)
CL Item
Disease progression (Disease progression)
C0242656 (UMLS CUI-1)
CL Item
Other, specify (Other, specify)
C0205394 (UMLS CUI-1)
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate) (Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate))
C0877248 (UMLS CUI-1)
Other
Item
If other, please specify
text
C0205394 (UMLS CUI [1])

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial